NEWS & INSIGHTS

The science

Explore the science behind rare cases of exceptional cancer survival, from cancer biology and multi-omics to spatial biology and AI, as researchers work to uncover the biological mechanisms that can help explain why some patients survive far beyond expectations.

Biology | Multi-omics | Rosalind Study | Drug Discovery

https://shining-circumstances-346837.framer.app/news/crispr-cas9-cancer-target-discovery

How CRISPR-Cas9 helps validate cancer targets

Learn how CRISPR/Cas9 helps researchers test cancer genes, identify vulnerabilities and generate functional evidence for therapeutic target discovery.

Sep 8, 2026

activated-dendritic-cells-cancer-immunity-manchester-university

Activated Dendritic Cells: A Key Role in Cancer Immunity

Researchers from Cancer Research UK Manchester Institute identify activated dendritic cells as key coordinators of anti-cancer immune responses.

Aug 26, 2026

spatial-biology-glioblastoma

Spatial biology is changing how we understand glioblastoma

Spatial biology is changing how we understand glioblastoma

Aug 11, 2026

population-diversity-clinical-trial-oncology

How Patient Diversity in Clinical Trials Improves Cancer Research

Patient Population diversity is essential to discovering the biology of exceptional cancer survival

Jul 30, 2026

techbio-biotech-oncology-glossary-cure51-rosalind-study

Glossary: 10 Techbio, Biotech and oncology terms everyone should know

Glossary: Techbio, biotech and oncology terms everyone should know

Aug 20, 2026

promising-oncology-clinical-trials

Promising oncology clinical trials we're following closely

New cancer treatments: promising oncology clinical trials

Jul 6, 2026

exceptional-survivors-blueprint-defeat-cancer

Why do exceptional survivors hold the blueprint to defeating cancer?

We're turning the biology of exceptional cancer survivors into the next generation of cancer medicines

Jun 23, 2026

Dr-Deb-Schrafg-Oncology

What if improving cancer care started with listening more carefully to patients?

Patient perspective is the driving force behind our Rosalind Study

Jun 8, 2026

What happens when an exceptional cancer survivor is identified?

What happens when an exceptional cancer survivor is identified?

May 18, 2026

Emna-Makhlouf-Agathe-Lecaron-Ex-Vitro

Emna Makhlouf, Chief of Staff: "Working with cancer survivors gives a lot of purpose to what we do"

Emna Makhlouf, Chief of Staff, shares why our scientific approach feels positive

May 5, 2026

cure51-techbio-biotech-oncology-data-company-ai

TechBio vs Biotech: What's the Difference? (Complete Guide)

TechBio vs Biotech: What's the Difference? (Complete Guide)

Apr 14, 2026

precision-medicine-nicolas-wolikow

Our CEO Nicolas Wolikow: "Turning precision medicine into an operational reality"

A fundamental shift: precision medicine is becoming actionable

Apr 21, 2026

Contact us